$9.2 M raised during Series A investment round


We are pleased to announce that additional $1.2 M has been raised during a second closing of the Series A financing round.

Investors participating in this second closing are Rivermount, Tech Coast Angels and InnoSIGN Management Company BV. The $1.2M will be added to the $8M financing raised during the first closing of the Series A, and will be used for development and commercialization of InnoSIGN’s proprietary OncoSIGNal signaling pathway tests.

Category group 1
  • Select all
Category group 2
  • Select all